Because anti-P1 IgM levels showed the strongest reduction in patients with NAFLD and due to its high clinical reproducibility, further analyses were conducted using the anti-P1 IgM measurements. Here, CD40LG is linked to metabolic dysfunction-associated steatotic liver disease.